Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
Chardan Advises Health Sciences Acquisitions Corporation on Merger with Immunovant
-
BiomX to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Chardan Capital Markets Starts Chardan Healthcare Acquisition Corp. (CHAC) at Buy
-
BiomX Hosting Key Opinion Leader Symposium on Novel Phage Product for Acne Prone Skin
-
Chardan Healthcare Acquisition Corp. Announces Merger Agreement with BiomX Ltd.
-
Chardan Healthcare Acquisition Corp. (CHAC) Reports Merger Agreement with BiomX Ltd.
-
Chardan Healthcare Acquisition Corp. Announces Merger Agreement with BiomX Ltd.
-
Chardan Healthcare Acquisition Corp. Announces Merger Agreement with BiomX Ltd.
-
Chardan Serves as Lead Left Joint Book-Running Manager for Health Sciences Acquisitions Corporation
-
Chardan Healthcare Acquisition Corp. Announces Closing of Initial Public Offering
-
Chardan Healthcare Acquisition Corp. (CHAC) Prices 7M Unit IPO at $10/Unit
-
Chardan Healthcare Acquisition Corp. Announces Pricing of $70 Million Initial Public Offering
